William Hilson
Presidente en Diamond Therapeutics, Inc. .
Cargos activos de William Hilson
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Cronos Growing Co., Inc.
Cronos Growing Co., Inc. Real Estate DevelopmentFinance Cronos Growing Co., Inc. provides cannabis products. It specializes in cannabis farming, cannabis cultivation and extraction products. The company is headquartered in Toronto, Canada. | Director/Miembro de la Junta | - | - |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | Presidente | - | - |
Silvermine Arts Center | Director/Miembro de la Junta | - | - |
Historial de carrera de William Hilson
Antiguos cargos conocidos de William Hilson.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
MERCK KGAA | Corporate Officer/Principal | - | - |
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Corporate Officer/Principal | - | - |
CRONOS GROUP INC. | Director Financiero/CFO | 06/10/2016 | 15/04/2019 |
Corporate Officer/Principal | 15/04/2019 | - |
Formación de William Hilson.
University of Western Ontario | Graduate Degree |
University of Toronto | Undergraduate Degree |
Estadísticas
Internacional
Canadá | 6 |
Alemania | 2 |
Suiza | 2 |
Operativa
Corporate Officer/Principal | 3 |
Director/Board Member | 2 |
Director of Finance/CFO | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 3 |
Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
CRONOS GROUP INC. | Health Technology |
MERCK KGAA | Health Technology |
Empresas privadas | 4 |
---|---|
Serono SA
Serono SA Pharmaceuticals: MajorHealth Technology Serono SA develops products to fight debilitating diseases and other pharmaceutical products. The company has eight biotechnology products on the market and a strong pipeline based on both proteins and small molecules. It's four main Therapeutics Areas are: Reproductive Health, Multiple Sclerosis, Growth & Metabolism, and Dermatology. It focuses on recombinant genetic engineering to develop drugs. The firm also focuses on neurological, metabolic, and human growth disorders. Other products include treatments for growth hormone deficiency, and AIDS-related wasting. The company is headquarterd in Geneva, Switzerland. | Health Technology |
Cronos Growing Co., Inc.
Cronos Growing Co., Inc. Real Estate DevelopmentFinance Cronos Growing Co., Inc. provides cannabis products. It specializes in cannabis farming, cannabis cultivation and extraction products. The company is headquartered in Toronto, Canada. | Finance |
Diamond Therapeutics, Inc.
Diamond Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Diamond Therapeutics, Inc. is a Canadian clinical-stage drug development company founded in 2018 by Judy Blumstock. The company is based in an undisclosed location and is focused on developing safe, FDA, EMA, and Health Canada approved therapies for neuropsychiatric conditions. The company is developing sub-perceptual, non-hallucinogenic, psychedelic-based treatments that hold potential for use across a broad patient cohort, with the goal of maximizing the positive impact better drugs can have on the mental health crisis. Diamond's mission is to develop new and better therapies for mental health conditions by unlocking the promise of psychedelic compounds. | Health Technology |
Silvermine Arts Center |
- Bolsa de valores
- Insiders
- William Hilson
- Experiencia